Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45237, United States.
Biochemistry. 2010 Dec 21;49(50):10656-65. doi: 10.1021/bi1015452. Epub 2010 Nov 23.
It is expected that the attendant structural heterogeneity of human high-density lipoprotein (HDL) complexes is a determinant of its varied metabolic functions. To determine the structural heterogeneity of HDL, we determined major apolipoprotein stoichiometry profiles in human HDL. First, HDL was separated into two main populations, with and without apolipoprotein (apo) A-II, LpA-I and LpA-I/A-II, respectively. Each main population was further separated into six individual subfractions using size exclusion chromatography (SEC). Protein proximity profiles (PPPs) of major apolipoproteins in each individual subfraction was determined by optimally cross-linking apolipoproteins within individual particles with bis(sulfosuccinimidyl) suberate (BS(3)), a bifunctional cross-linker, followed by molecular mass determination by MALDI-MS. The PPPs of LpA-I subfractions indicated that the number of apoA-I molecules increased from two to three to four with an increase in the LpA-I particle size. On the other hand, the entire population of LpA-I/A-II demonstrated the presence of only two proximal apoA-I molecules per particle, while the number of apoA-II molecules varied from one dimeric apoA-II to two and then to three. For most of the PPPs described above, an additional population that contained a single molecule of apoC-III in addition to apoA-I and/or apoA-II was detected. Upon composition analyses of individual subpopulations, LpA-I/A-II exhibited comparable proportions for total protein (∼58%), phospholipids (∼21%), total cholesterol (∼16%), triglycerides (∼5%), and free cholesterol (∼4%) across subfractions. LpA-I components, on the other hand, showed significant variability. This novel information about HDL subfractions will form a basis for an improved understanding of particle-specific functions of HDL.
预计人类高密度脂蛋白 (HDL) 复合物的伴随结构异质性是其多种代谢功能的决定因素。为了确定 HDL 的结构异质性,我们测定了人 HDL 中主要载脂蛋白的化学计量比谱。首先,HDL 被分离成两个主要群体,分别含有和不含有载脂蛋白 (apo) A-II、LpA-I 和 LpA-I/A-II。每个主要群体进一步使用尺寸排阻色谱 (SEC) 分离成六个个体亚组分。通过用双(磺基琥珀酰亚胺基)琥珀酸酯 (BS(3)) 最佳交联单个颗粒内的载脂蛋白,BS(3)是一种双功能交联剂,随后通过 MALDI-MS 测定分子量,确定每个个体亚组分中主要载脂蛋白的蛋白接近度谱 (PPP)。LpA-I 亚组分的 PPP 表明,随着 LpA-I 颗粒尺寸的增加,apoA-I 分子的数量从两个增加到三个再增加到四个。另一方面,整个 LpA-I/A-II 群体仅显示每个颗粒存在两个近端 apoA-I 分子,而 apoA-II 分子的数量从一个二聚 apoA-II 变化到两个然后到三个。对于上述大多数 PPP,除了 apoA-I 和/或 apoA-II 之外,还检测到含有单个 apoC-III 分子的另外群体。在对个体亚群进行成分分析后,LpA-I/A-II 显示各亚组分的总蛋白(58%)、磷脂(21%)、总胆固醇(16%)、甘油三酯(5%)和游离胆固醇(~4%)的比例相当。另一方面,LpA-I 成分表现出显著的可变性。关于 HDL 亚组分的这些新信息将为更好地理解 HDL 颗粒特定功能奠定基础。